MX2007010681A - Composiciones de geles locales. - Google Patents

Composiciones de geles locales.

Info

Publication number
MX2007010681A
MX2007010681A MX2007010681A MX2007010681A MX2007010681A MX 2007010681 A MX2007010681 A MX 2007010681A MX 2007010681 A MX2007010681 A MX 2007010681A MX 2007010681 A MX2007010681 A MX 2007010681A MX 2007010681 A MX2007010681 A MX 2007010681A
Authority
MX
Mexico
Prior art keywords
nsai
composition
drug
pro
amount
Prior art date
Application number
MX2007010681A
Other languages
English (en)
Spanish (es)
Inventor
Monique Spann-Wade
Anthony J Ward
Original Assignee
Isw Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/361,384 external-priority patent/US20070053984A1/en
Application filed by Isw Group Inc filed Critical Isw Group Inc
Publication of MX2007010681A publication Critical patent/MX2007010681A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2007010681A 2005-03-03 2006-02-27 Composiciones de geles locales. MX2007010681A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US65808405P 2005-03-03 2005-03-03
US68110205P 2005-05-13 2005-05-13
US69020105P 2005-06-14 2005-06-14
US11/361,384 US20070053984A1 (en) 2005-03-03 2006-02-24 Topical gels compositions
PCT/US2006/006780 WO2006096360A1 (en) 2005-03-03 2006-02-27 Topical gels compositions

Publications (1)

Publication Number Publication Date
MX2007010681A true MX2007010681A (es) 2007-12-07

Family

ID=42334238

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007010681A MX2007010681A (es) 2005-03-03 2006-02-27 Composiciones de geles locales.

Country Status (10)

Country Link
EP (1) EP1858503B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008531693A (cg-RX-API-DMAC7.html)
KR (1) KR20080008321A (cg-RX-API-DMAC7.html)
AU (1) AU2006220964A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0608077A2 (cg-RX-API-DMAC7.html)
CA (1) CA2599968A1 (cg-RX-API-DMAC7.html)
ES (1) ES2437201T3 (cg-RX-API-DMAC7.html)
IL (1) IL185531A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007010681A (cg-RX-API-DMAC7.html)
WO (1) WO2006096360A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7914814B2 (en) 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
AU2005235308B2 (en) 2004-04-19 2011-12-01 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20080317684A1 (en) * 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
CA2666398C (en) 2006-10-17 2015-08-18 Ed Kisak Diclofenac gel
ES2316312B1 (es) * 2008-06-20 2010-02-08 Ignacio Umbert Millet Composicion farmaceutica dermatologica para el tratamiento de patologias de inflamacion de la piel, tales como por ejemplo dermatitis, dermatitis atopica, vitiligo, alopecia areata, acne, psoriasis y prurito,y combinaciones de las mismas.
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
AU2009348470B2 (en) * 2009-06-24 2015-04-02 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
EP2445493A1 (en) * 2009-06-24 2012-05-02 Strategic Science & Technologies, LLC Topical composition containing naproxen
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
AU2015203547B2 (en) * 2009-06-24 2017-05-18 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
JP2011106846A (ja) * 2009-11-13 2011-06-02 Hamamatsu Univ School Of Medicine 新規ｎｓａｉｄ潰瘍リスク判定方法
KR101141938B1 (ko) * 2010-01-22 2012-05-04 성균관대학교산학협력단 신규한 항생제 조성물 및 그람양성균의 치료 방법
JP2014504592A (ja) 2010-12-29 2014-02-24 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 勃起不全および他の適応症の処置
JP2014501283A (ja) 2010-12-29 2014-01-20 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー アレルギーおよび他の適応症の処置のためのシステムおよび方法
DK2704703T3 (da) 2011-05-03 2019-10-14 Aponia Laboratories Inc Transdermale sammensætninger af ibuprofen og fremgangsmåder til anvendelse deraf
EP3113849B1 (en) 2014-02-26 2019-06-12 Luma Therapeutics, Inc. Ultraviolet phototherapy apparatus
KR20180134856A (ko) 2016-02-09 2018-12-19 루마 세러퓨틱스 인코포레이티드 광선요법에 의해 건선을 치료하기 위한 방법, 조성물 및 장치
US20200230082A1 (en) * 2017-07-11 2020-07-23 University Of Miami Topical acetaminophen formulations for itch relief
US20230398060A1 (en) * 2020-05-19 2023-12-14 Mig Usa, Llc Topical compositions and methods for treating pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS596287B2 (ja) * 1980-11-28 1984-02-10 日東電工株式会社 医薬製剤
WO1987002891A1 (en) 1985-11-07 1987-05-21 Pfizer Inc. Compounds and method for the topical treatment of inflammation and pain
US5093133A (en) 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
US5639738A (en) 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
US5976566A (en) 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin

Also Published As

Publication number Publication date
AU2006220964A1 (en) 2006-09-14
CA2599968A1 (en) 2006-09-14
IL185531A0 (en) 2008-01-06
BRPI0608077A2 (pt) 2009-11-10
EP1858503B1 (en) 2013-09-04
EP1858503A1 (en) 2007-11-28
WO2006096360A1 (en) 2006-09-14
JP2008531693A (ja) 2008-08-14
KR20080008321A (ko) 2008-01-23
ES2437201T3 (es) 2014-01-09

Similar Documents

Publication Publication Date Title
US20100158993A1 (en) Topical Gel Compositions
EP1858503B1 (en) Topical gels compositions
CA2662434C (en) Topical nsaid compositions with increased solubility
US5807568A (en) Enhanced delivery of topical compositions containing flurbiprofen
US20140314815A1 (en) Adhesive solid gel-forming formulations for dermal drug delivery
CA2288706C (en) Use of high dose retinoids for the treatment of skin disorders
US8815953B2 (en) Formulations of vitamin K analogs for topical use
JP2000501429A (ja) 局所治療用および化粧用製剤の組成物基剤
EP2504034A1 (en) Topical ibuprofen formulations
US20050137164A1 (en) Diclofenac compositions for the treatment of skin disorders
US20110281947A1 (en) Methods of administering diclofenac compositions for treating photodamaged skin
ZA200707357B (en) Detection of very virulent infectious bursal disease virus
JP5667052B2 (ja) ダナゾールを含む経真皮医薬組成物
CN101541321A (zh) 局部用组合物
CN101151028A (zh) 局部用凝胶组合物
CA3222314A1 (en) Diclofenac topical formulation with a high absorption rate
HK1119058A (en) Topical gels compositions
JP2012126733A (ja) 外用医薬組成物
MXPA05006082A (es) Proceso para la estabilizacion quimica de un retinoide solubilizado en un solvente usando una base.
WO2022189945A1 (en) Topical cannabinoid compositions and methods for treating skin diseases

Legal Events

Date Code Title Description
FA Abandonment or withdrawal